Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors. Clinics, [S. l.], v. 69, n. 4, p. 294–303, 2014. DOI: 10.1590/clin.v69i4.79512. Disponível em: https://www.revistas.usp.br/clinics/article/view/79512.. Acesso em: 20 may. 2024.